IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies.
Saved in:
| Title: | IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies. |
|---|---|
| Authors: | Audsley KM; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Wagner T; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia., Ta C; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Newnes HV; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Buzzai AC; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia.; Department of Experimental Dermatology, University of Magdeburg, Magdeburg, Germany., Barnes SA; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Wylie B; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Armitage J; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Kaisho T; Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan., Bosco A; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., McDonnell A; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Cruickshank M; School of Biomedical Sciences, The University of Western Australia, Nedlands, WA, Australia., Fear VS; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Foley B; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia., Waithman J; Telethon Kids Institute, The University of Western Australia, Nedlands, WA, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Sep 06; Vol. 12, pp. 735133. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
